Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients.

Saved in:

Bibliographic Details
Title:	Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients.
Authors:	Terpos, Evangelos^1,2, Mougiou, Athina³, Kouraklis, Alexandra⁴, Chatzivassili, Aria⁵, Michalis, Evridiki⁶, Giannakoulas, Nicholas⁷, Manioudaki, Eleni⁸, Lazaridou, Anna⁹, Bakaloudi, Vassiliki⁹, Protopappa, Maria¹⁰, Liapi, Dimitra⁵, Grouzi, Elisavet¹¹, Parharidou, Agapi¹², Symeonidis, Argyris⁴, Kokkini, Garoufalia¹³, Laoutaris, Nikolaos P.⁸, Vaipoulos, George¹⁴, Anagnostopoulos, Nikolaos I.⁶, Christakis, John I.⁹, Meletis, John¹⁴
Source:	British Journal of Haematology. Jul2002, Vol. 118 Issue 1, p174-180. 7p.
Database:	Academic Search Ultimate

Description
ISSN:	00071048
DOI:	10.1046/j.1365-2141.2002.03583.x